Altai Protocol Library
1041 protocols and counting
All protocols with references and links
All protocols reviewed by a Medical Oncologist/Hematologist
All protocols in major guidelines included
Ability to create your own protocols
New Reference: Pembrolizumab for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer
Study: Randomised, open-label, phase 3 study (KEYNOTE-177) Untreated microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer Pembrolizumab 200 mg every 3 weeks (N:153) or to the investigator’s choice (N:154) Efficacy:
New Reference: Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
Study: Double-blind, randomized, placebo-controlled, phase 3 trial Newly diagnosed IDH1-mutated acute myeloid leukemia Ineligible for intensive induction chemotherapy Oral ivosidenib and azacitidine (N:72) or placebo and azacitidine (N:74) Efficacy: HR